Skandinaviska Enskilda Banken (SEB)
DGX icon

Skandinaviska Enskilda Banken (SEB)’s Quest Diagnostics DGX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-139,936
Closed -$24.3M – 314
2025
Q4 		$24.3M Sell
139,936
-21,980
-14% -$4M 0.1% 158
2025
Q3 		$30.9M Sell
161,916
-27,243
-14% -$4.83M 0.12% 139
2025
Q2 		$34M Buy
189,159
+56,082
+42% +$9.74M 0.15% 120
2025
Q1 		$22.5M Buy
133,077
+107,033
+411% +$17.6M 0.11% 156
2024
Q4 		$3.93M Buy
26,044
+2,900
+13% +$451K 0.02% 451
2024
Q3 		$3.59M Hold
23,144
– – 0.02% 476
2024
Q2 		$3.17M Sell
23,144
-177,800
-88% -$24.3M 0.02% 470
2024
Q1 		$26.7M Buy
200,944
+72,026
+56% +$9.35M 0.13% 143
2023
Q4 		$17.8M Sell
128,918
-7,908
-6% -$1.04M 0.1% 189
2023
Q3 		$16.7M Sell
136,826
-26,198
-16% -$3.49M 0.11% 174
2023
Q2 		$22.9M Sell
163,024
-5,572
-3% -$768K 0.15% 141
2023
Q1 		$23.9M Sell
168,596
-9,754
-5% -$1.4M 0.17% 131
2022
Q4 		$27.9M Buy
178,350
+19,069
+12% +$2.74M 0.21% 113
2022
Q3 		$19.5M Sell
159,281
-39,806
-20% -$5.24M 0.15% 133
2022
Q2 		$26.5M Sell
199,087
-136,581
-41% -$18.6M 0.19% 107
2022
Q1 		$45.9M Sell
335,668
-88,930
-21% -$12.4M 0.27% 80
2021
Q4 		$72.8M Sell
424,598
-122,490
-22% -$18.6M 0.37% 51
2021
Q3 		$79.5M Buy
547,088
+113,286
+26% +$16.6M 0.44% 47
2021
Q2 		$57.2M Buy
433,802
+66,766
+18% +$8.74M 0.35% 64
2021
Q1 		$47.1M Sell
367,036
-173,881
-32% -$21.4M 0.31% 71
2020
Q4 		$64.5M Buy
540,917
+142,970
+36% +$17.4M 0.44% 48
2020
Q3 		$45.6M Buy
397,947
+33,701
+9% +$3.98M 0.33% 70
2020
Q2 		$41.5M Buy
364,246
+325,034
+829% +$34.5M 0.34% 65
2020
Q1 		$3.15M Buy
39,212
+2,340
+6% +$242K 0.03% 370
2019
Q4 		$3.94M Sell
36,872
-13,351
-27% -$1.39M 0.03% 393
2019
Q3 		$5.38M Buy
50,223
+849
+2% +$87.2K 0.05% 306
2019
Q2 		$5.03M Sell
49,374
-34,198
-41% -$3.29M 0.04% 312
2019
Q1 		$7.51M Sell
83,572
-244,990
-75% -$21.2M 0.07% 227
2018
Q4 		$27.4M Sell
328,562
-969,829
-75% -$90.9M 0.25% 93
2018
Q3 		$140M Sell
1,298,391
-48,230
-4% -$5.29M 1.06% 24
2018
Q2 		$148M Buy
1,346,621
+6,241
+0.5% +$650K 1.26% 20
2018
Q1 		$134M Buy
1,340,380
+524,662
+64% +$53.7M 1.3% 17
2017
Q4 		$80.3M Sell
815,718
-841,432
-51% -$79.8M 0.69% 38
2017
Q3 		$155M Buy
1,657,150
+190,000
+13% +$20.2M 1.41% 11
2017
Q2 		$163M Buy
1,467,150
+7,200
+0.5% +$761K 1.57% 9
2017
Q1 		$143M Buy
1,459,950
+7,285
+0.5% +$694K 1.45% 14
2016
Q4 		$134M Sell
1,452,665
-76,187
-5% -$6.57M 1.6% 16
2016
Q3 		$129M Buy
1,528,852
+6,489
+0.4% +$545K 1.4% 18
2016
Q2 		$124M Sell
1,522,363
-1,400
-0.1% -$107K 1.39% 20
2016
Q1 		$109M Sell
1,523,763
-600
-0% -$40.2K 1.22% 23
2015
Q4 		$108M Buy
+1,524,363
New +$102M 1.4% 20

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s DGX Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 139,936 shares — an estimated $24.3M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in DGX in Q4 2015 and held it in 41 quarters. The position peaked at $163M in Q2 2017. 1,069 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 139,936 Quest Diagnostics shares in Q1 2026, an estimated $24.3M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Quest Diagnostics in Q4 2015 and held it in 41 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Quest Diagnostics position peaked at $163M in Q2 2017.
  • 1,069 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.